66331-1-Ig
antibody from Proteintech Group
Targeting: GOLM1
bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66331-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- GP73/GOLPH2 antibody
- Antibody type
- Monoclonal
- Description
- GP73/GOLPH2 antibody (Cat. #66331-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 3D1F1
- Vial size
- 20ul, 150ul
Submitted references PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1.
Associating bovine herpesvirus 1 envelope glycoprotein gD with activated phospho-PLC-γ1(S1248).
Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma.
TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
Huang F, Guo J, Zhao N, Hou M, Gai X, Yang S, Cai P, Wang Y, Ma Q, Zhao Q, Li L, Yang H, Jing Y, Jin D, Hu Z, Zha X, Wang H, Mao Y, Liu F, Zhang H
Journal of translational medicine 2024 Mar 8;22(1):254
Journal of translational medicine 2024 Mar 8;22(1):254
Associating bovine herpesvirus 1 envelope glycoprotein gD with activated phospho-PLC-γ1(S1248).
Liu C, Yuan W, Yang H, Ni J, Tang L, Zhao H, Neumann D, Ding X, Zhu L
Microbiology spectrum 2023 Sep 1;11(5):e0196323
Microbiology spectrum 2023 Sep 1;11(5):e0196323
Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma.
Shao WQ, Zhu WW, Luo MJ, Fan MH, Li Q, Wang SH, Lin ZF, Zhao J, Zheng Y, Dong QZ, Lu L, Jia HL, Zhang JB, Lu M, Chen JH, Qin LX
Cell reports 2022 Apr 19;39(3):110712
Cell reports 2022 Apr 19;39(3):110712
TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
Wang M, Ren Y, Hu S, Liu K, Qiu L, Zhang Y
Frontiers in oncology 2021;11:707032
Frontiers in oncology 2021;11:707032
No comments: Submit comment
No validations: Submit validation data